Rhumbline Advisers »

Armata Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Armata Pharmaceuticals (ARMP) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Armata Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Armata Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Armata Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $55k 8.5k 6.48

More positions owned by Rhumbline Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Micron Technology (MU)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Visa (V)

View all positions for Rhumbline Advisers

Top funds holding Armata Pharmaceuticals

Madison Asset Management
BlackRock
Vanguard Capital Management
Millennium Management
Geode Capital Management
Dauntless Investment Group
Northern Trust
Vanguard Portfolio Management
Edgewood Management
Vanguard Fiduciary Trust
State Street Corporation
GSB Wealth Management
Renaissance Technologies
Bridgeway Capital Management
SeaCrest Wealth Management

View all funds holding Armata Pharmaceuticals